IL115738A - נוגדני פרוג'סטרון תחרותיים להסדרת פוריות נשית כנדרש - Google Patents
נוגדני פרוג'סטרון תחרותיים להסדרת פוריות נשית כנדרשInfo
- Publication number
- IL115738A IL115738A IL11573895A IL11573895A IL115738A IL 115738 A IL115738 A IL 115738A IL 11573895 A IL11573895 A IL 11573895A IL 11573895 A IL11573895 A IL 11573895A IL 115738 A IL115738 A IL 115738A
- Authority
- IL
- Israel
- Prior art keywords
- phenyl
- hydroxy
- competitive progesterone
- progesterone antagonist
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4438820 | 1994-10-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL115738A0 IL115738A0 (en) | 1996-01-19 |
| IL115738A true IL115738A (he) | 2002-05-23 |
Family
ID=6532105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11573895A IL115738A (he) | 1994-10-24 | 1995-10-24 | נוגדני פרוג'סטרון תחרותיים להסדרת פוריות נשית כנדרש |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6143754A (he) |
| EP (1) | EP0787002B1 (he) |
| JP (1) | JPH10507461A (he) |
| KR (1) | KR970706827A (he) |
| CN (1) | CN1211087C (he) |
| AT (1) | ATE347894T1 (he) |
| AU (1) | AU707235B2 (he) |
| BG (1) | BG62877B1 (he) |
| BR (1) | BR9509478A (he) |
| CA (1) | CA2203541A1 (he) |
| CZ (1) | CZ290690B6 (he) |
| DE (1) | DE59511071D1 (he) |
| DK (1) | DK0787002T3 (he) |
| ES (1) | ES2279515T3 (he) |
| FI (1) | FI971742A0 (he) |
| HU (1) | HU226566B1 (he) |
| IL (1) | IL115738A (he) |
| NO (1) | NO314437B1 (he) |
| NZ (1) | NZ295365A (he) |
| PL (1) | PL319869A1 (he) |
| PT (1) | PT787002E (he) |
| RO (1) | RO120606B1 (he) |
| SK (1) | SK283662B6 (he) |
| WO (1) | WO1996012494A1 (he) |
| ZA (1) | ZA959008B (he) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19745085A1 (de) * | 1997-10-11 | 1999-04-15 | Jenapharm Gmbh | 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
| DE19809845A1 (de) | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
| CZ301412B6 (cs) * | 1999-08-31 | 2010-02-24 | Bayer Schering Pharma Aktiengesellschaft | Použití specifických mesoprogestinu jako farmaceutické složky pro výrobu léciva pro hormonální substitucní lécbu |
| US7629334B1 (en) | 1999-08-31 | 2009-12-08 | Bayer Schering Pharma Aktiengesellschaft | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) |
| PL353994A1 (en) * | 1999-08-31 | 2003-12-15 | Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| WO2009082478A1 (en) * | 2007-12-20 | 2009-07-02 | Duramed Pharmaceuticals, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
| SI2419108T1 (sl) | 2009-04-14 | 2017-02-28 | Laboratorie Hra Pharma | Metoda za kontracepcijo na zahtevo |
| US20120129825A1 (en) * | 2009-04-14 | 2012-05-24 | Andre Ulmann | Method for on-demand contraception using levonorgestrel or norgestrel |
| BR112015029214A2 (pt) | 2013-05-23 | 2017-07-25 | Bayer Pharma AG | composição farmacêutica, seu uso e regime de aplicação dessa composição farmacêutica para contracepção conforme a necessidade |
| CN113559075A (zh) | 2014-11-17 | 2021-10-29 | 康泰科思特生物制药公司 | 奥那司酮延长释放组合物和方法 |
| BR112018005999A2 (pt) | 2015-09-25 | 2019-01-08 | Context Biopharma Inc | métodos para a produção de intermediários de onapristona |
| MX2018007154A (es) | 2015-12-15 | 2019-01-10 | Context Biopharma Inc | Composiciones de onapristona amorfa y metodos para hacer las mismas. |
| US20180148471A1 (en) | 2016-11-30 | 2018-05-31 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5439913A (en) * | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
-
1995
- 1995-10-24 JP JP8513655A patent/JPH10507461A/ja active Pending
- 1995-10-24 PT PT95937845T patent/PT787002E/pt unknown
- 1995-10-24 IL IL11573895A patent/IL115738A/he not_active IP Right Cessation
- 1995-10-24 NZ NZ295365A patent/NZ295365A/xx unknown
- 1995-10-24 CZ CZ19971180A patent/CZ290690B6/cs not_active IP Right Cessation
- 1995-10-24 EP EP95937845A patent/EP0787002B1/de not_active Expired - Lifetime
- 1995-10-24 DK DK95937845T patent/DK0787002T3/da active
- 1995-10-24 HU HU9702177A patent/HU226566B1/hu not_active IP Right Cessation
- 1995-10-24 RO RO97-00635A patent/RO120606B1/ro unknown
- 1995-10-24 CA CA002203541A patent/CA2203541A1/en not_active Abandoned
- 1995-10-24 DE DE59511071T patent/DE59511071D1/de not_active Expired - Fee Related
- 1995-10-24 BR BR9509478A patent/BR9509478A/pt active Search and Examination
- 1995-10-24 AU AU38696/95A patent/AU707235B2/en not_active Ceased
- 1995-10-24 WO PCT/EP1995/004191 patent/WO1996012494A1/de active IP Right Grant
- 1995-10-24 AT AT95937845T patent/ATE347894T1/de not_active IP Right Cessation
- 1995-10-24 CN CNB951958178A patent/CN1211087C/zh not_active Expired - Fee Related
- 1995-10-24 SK SK518-97A patent/SK283662B6/sk unknown
- 1995-10-24 ZA ZA959008A patent/ZA959008B/xx unknown
- 1995-10-24 ES ES95937845T patent/ES2279515T3/es not_active Expired - Lifetime
- 1995-10-24 PL PL95319869A patent/PL319869A1/xx unknown
-
1997
- 1997-04-21 BG BG101427A patent/BG62877B1/bg unknown
- 1997-04-23 FI FI971742A patent/FI971742A0/fi unknown
- 1997-04-23 NO NO19971869A patent/NO314437B1/no unknown
- 1997-04-24 KR KR1019970702695A patent/KR970706827A/ko active Search and Examination
-
1999
- 1999-03-22 US US09/273,485 patent/US6143754A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6362237B1 (en) | Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception | |
| US6225297B1 (en) | Combination contraceptive | |
| US5719136A (en) | Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women | |
| EP0792152B1 (en) | Methods of contraception | |
| US6043234A (en) | Method for treating endometriosis or leiomyomata uteri with a competitive progesterone antagonist and a gestagen | |
| CZ290612B6 (cs) | Antikoncepční činidlo a sloučeniny pro antikoncepci | |
| US6143754A (en) | Competitive progesterone antagonist for demand-oriented female birth control | |
| US20010016578A1 (en) | Compositions and methods for contraception and for treatment of benign gynecological disorders | |
| Bygdeman et al. | Contraceptive use of antiprogestin | |
| BG106441A (bg) | Мезопрогестини (модулатори на прогестероновия рецептор) като компоненти на женски контрацептиви | |
| JPH08510992A (ja) | 受精の阻止及び防止方法 | |
| MXPA97003018A (es) | Antagonistas de progesterona competentes para regular la fertilidad femenina segun se requiera | |
| Puri | Antiprogestins: useful investigative tools and novel contraceptives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |